Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease

References

• Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996;38:365–375.
   PubMed Web of Science ®Google Scholar
• Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296–1306.
   PubMed Web of Science ®Google Scholar
• Rieder F, Kugathasan S. Circulating antibodies against bacterial wall products: are there arguments for early immunosuppression? Dig Dis. 2012;30:55–66.
   PubMed Web of Science ®Google Scholar
• Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology. 2006;130:1764–1775.
   PubMed Web of Science ®Google Scholar
• Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788–791.
   PubMed Web of Science ®Google Scholar
• Hochwallner H, Schulmeister U, Swoboda I, et al. Patients suffering from non-IgE-mediated cow's milk protein intolerance cannot be diagnosed based on IgG subclass or IgA responses to milk allergens. Allergy. 2011;66:1201–1207.
   PubMed Web of Science ®Google Scholar
• Frehn L, Jansen A, Bennek E, et al. Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseases. PLoS One. 2014;9:e106750.
   PubMed Web of Science ®Google Scholar
• Panel NI-SE, Boyce JA, Assa'ad A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126:S1–S58.
   PubMed Web of Science ®Google Scholar
• Atkinson W, Sheldon TA, Shaath N, et al. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53:1459–1464.
   PubMed Web of Science ®Google Scholar
• Bentz S, Hausmann M, Piberger H, et al. Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double-blind cross-over diet intervention study. Digestion. 2010;81:252–264.
   PubMed Web of Science ®Google Scholar
• Rajendran N, Kumar D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn's disease: a pilot study. Colorectal Dis. 2011;13:1009–1013.
   PubMed Web of Science ®Google Scholar
• Lindberg E, Magnusson KE, Tysk C, et al. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut. 1992;33:909–913.
   PubMed Web of Science ®Google Scholar
• Lerner A, Rossi TM, Park B, et al. Serum antibodies to cow's milk proteins in pediatric inflammatory bowel disease. Crohn's disease versus ulcerative colitis. Acta Paediatr Scand. 1989;78:384–389.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Fukuda Y, Koizuka H, et al. Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase. Am J Gastroenterol. 2008;103:656–664.
   PubMed Web of Science ®Google Scholar
• Cai C, Shen J, Zhao D, et al. Serological investigation of food specific immunoglobulin g antibodies in patients with inflammatory bowel diseases. PLoS One. 2014;9:e112154
   PubMed Web of Science ®Google Scholar
• Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 2014;5:520.
   PubMed Web of Science ®Google Scholar
• Bruhns P, Iannascoli B, England P, et al. Specificity and affinity of human Fc-gamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113:3716–3725.
   PubMed Web of Science ®Google Scholar
• Burton DR, Gregory L, Jefferis R. Aspects of the molecular structure of IgG subclasses. Monogr Allergy. 1986;19:7–35.
   PubMedGoogle Scholar
• Stevens R, Dichek D, Keld B, et al. IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol. 1983;3:65–69.
   PubMed Web of Science ®Google Scholar
• Siber GR, Schur PH, Aisenberg AC, et al. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med. 1980;303:178–182.
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133:621–631.
   PubMed Web of Science ®Google Scholar
• Durandy A, Kracker S, Fischer A. Primary antibody deficiencies. Nat Rev Immunol. 2013;13:519–533.
   PubMed Web of Science ®Google Scholar
• Philipsen EK, Bondesen S, Andersen J, et al. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities. Scand J Gastroenterol. 1995;30:50–53.
   PubMed Web of Science ®Google Scholar
• Scott MG, Nahm MH, Macke K, et al. Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Clin Exp Immunol. 1986;66:209–215.
   PubMed Web of Science ®Google Scholar
• MacDermott RP, Nash GS, Auer IO, et al. Alterations in serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease. Gastroenterology. 1989;96:764–768.
   PubMed Web of Science ®Google Scholar
• Gouni-Berthold I, Baumeister B, Berthold HK, et al. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease. Hepatogastroenterology. 1999;46:1720–1723.
   PubMed Web of Science ®Google Scholar
• Kett K, Rognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology. 1987;93:919–924.
   PubMed Web of Science ®Google Scholar
• Ruthlein J, Ibe M, Burghardt W, et al. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects. Gut. 1992;33:507–512.
   PubMed Web of Science ®Google Scholar
• Arato A, Savilahti E. IgG3 and IgG4 cells are increased in active ulcerative colitis. Digestion. 1990;47:35–41.
   PubMed Web of Science ®Google Scholar
• Oshitani N, Hato F, Jinno Y, et al. IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatory bowel disease. Eur J Clin Invest. 2001;31:221–225.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29–32.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–753.
   PubMed Web of Science ®Google Scholar
• Rieder F, Schleder S, Wolf A, et al. Serum anti-glycan antibodies predict complicated Crohn's disease behavior. A cohort study. Inflamm Bowel Dis. 2010;16:1367–1375.
   PubMed Web of Science ®Google Scholar
• Papp M, Altorjay I, Dotan N, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol. 2008;103:665–681.
   PubMed Web of Science ®Google Scholar
• Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689–699.
   PubMed Web of Science ®Google Scholar
• Dotan I, Fishman S, Dgani Y, et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006;131:366–378.
   PubMed Web of Science ®Google Scholar
• Terjung B, Sohne J, Lechtenberg B, et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut. 2010;59:808–816.
   PubMed Web of Science ®Google Scholar
• van der Neut Kolfschoten M, Schuurman J, Losen M, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science. 2007;317:1554–1557.
   PubMed Web of Science ®Google Scholar
• Ottesen EA, Skvaril F, Tripathy SP, et al. Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol. 1985;134:2707–2712.
   PubMed Web of Science ®Google Scholar
• Iskander R, Das PK, Aalberse RC. IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol. 1981;66:200–207.
   PubMedGoogle Scholar
• Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015;385:1460–1471.
   PubMed Web of Science ®Google Scholar
• Scott H, Rognum TO, Midtvedt T, et al. Age-related changes of human serum antibodies to dietary and colonic bacterial antigens measured by an enzyme-linked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C. 1985;93:65–70.
   PubMedGoogle Scholar
• Sicherer SH, Sampson HA. Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133:291–307.
   PubMed Web of Science ®Google Scholar
• Beyer K, Teuber SS. Food allergy diagnostics: scientific and unproven procedures. Curr Opin Allergy Clin Immunol. 2005;5:261–266.
   PubMed Web of Science ®Google Scholar
• Barnes RM, Harvey MM, Blears J, et al. IgG subclass of human serum antibodies reactive with dietary proteins. Int Arch Allergy Appl Immunol. 1986;81:141–147.
   PubMedGoogle Scholar